Sanofi (SNY) Cash from Operations (2009 - 2026)

Sanofi has disclosed Cash from Operations across 10 years of filings, most recently posting 2867156097.04 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 2867156097.04, up 24.98% year-over-year; the trailing twelve-month figure through Mar 2026 was 24200092241.56 (up 18.68% YoY), and the FY2025 annual result was 12513467783.01, up 28.95% from the prior year.
• Cash from Operations came in at 2867156097.04 for Q1 2026 at Sanofi, down from 11237676090.9 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 11967679607.6 in Q4 2023 to a low of 495368285.1 in Q2 2024.
• The 5-year median for Cash from Operations is 3057316838.85 (2022), against an average of 5212786967.77.
• Across the five-year window, Cash from Operations slumped 155.68% in 2024 and jumped 413.97% in 2025, its largest moves.
• Sanofi's Cash from Operations stood at 11195174339.4 in 2022, then climbed by 6.9% to 11967679607.6 in 2023, then dropped by 12.22% to 10505361379.0 in 2024, then rose by 6.97% to 11237676090.9 in 2025, then sank by 74.49% to 2867156097.04 in 2026.
• The last three Cash from Operations figures came in at 2867156097.04 (Q1 2026), 11237676090.9 (Q4 2025), and 8539947442.32 (Q3 2025), per Business Quant data.